We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
BCDA icon
926
BioCardia
BCDA
$13.8M
$13.8M $0.9131 0.92%
RADX icon
927
Radiopharm Theranostics
RADX
$13.6M
$13.6M $0.8690 2.37%
CUPR icon
928
Cuprina Holdings Cayman Ltd
CUPR
$13.4M
$13.4M $1.92 2.67%
BFRI icon
929
Biofrontera
BFRI
$13.4M
$13.4M $0.9038 1.56%
PAVM icon
930
PAVmed
PAVM
$13.3M
$13.3M $1.66 8.79%
DARE icon
931
Dare Bioscience
DARE
$13M
$13M $0.6619 1.83%
GUTS icon
932
Fractyl Health
GUTS
$12.9M
$12.9M $0.9725 8.27%
SCLX icon
933
Scilex Holding
SCLX
$12.9M
$12.9M $1.83 1.08%
OPTH icon
934
Optimi Health Corp
OPTH
$12.7M
$12.7M $2.21 4.74%
IRIX icon
935
IRIDEX
IRIX
$12.6M
$12.6M $0.7151 2.74%
SINT icon
936
SiNtx Technologies
SINT
$12.5M
$12.5M $1.66 3.49%
AEON icon
937
AEON Biopharma
AEON
$12.3M
$12.3M $0.2086 1.7%
HIND icon
938
Vyome Holdings
HIND
$12.2M
$12.2M $1.74 1.69%
CLGN icon
939
CollPlant Biotechnologies
CLGN
$12.2M
$12.2M $4.23 2.92%
PBM icon
940
Psyence Biomedical
PBM
$12.1M
$12.1M $3.18 3.34%
FEMY icon
941
Femasys
FEMY
$12.1M
$12.1M $1.44 2.86%
LPCN icon
942
Lipocine
LPCN
$11.9M
$11.9M $1.44 1.37%
BIVI icon
943
BioVie
BIVI
$11.6M
$11.6M $1.34 22.5%
CLRB icon
944
Cellectar Biosciences
CLRB
$11.6M
$11.6M $1.23 6.11%
TVRD icon
945
Tvardi Therapeutics
TVRD
$11.5M
$11.5M $0.8614 3.17%
LSTA icon
946
Lisata Therapeutics
LSTA
$11.5M
$11.5M $1.06 2.75%
INTS icon
947
Intensity Therapeutics
INTS
$11.4M
$11.4M $3.50 3.55%
PASG icon
948
Passage Bio
PASG
$11.3M
$11.3M $3.51 3.24%
ICU icon
949
SeaStar Medical
ICU
$10.8M
$10.8M $2.04 2%
PTN icon
950
Palatin Technologies
PTN
$10.7M
$10.7M $6.02 15.3%
36 37
38
39 40

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,118 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $10.3T.

The largest by market cap are Eli Lilly (LLY) at $1.26T, Johnson & Johnson (JNJ) at $665B and AbbVie (ABBV) at $521B.

Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 531 funds opened new positions, taking total fund holders up 348 (11%) quarter-over-quarter.

  • Combined market cap: $10.3T across 1,118 stocks.
  • Largest constituent: Eli Lilly (LLY), $1.26T market cap.
  • Most net new fund positions in Q2 2026: UnitedHealth (UNH), +348 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.